[Radiotherapy for vulvar cancer].
Fifteen patients who had primary vulvar cancer treated with radiotherapy as an initial treatment at Hyogo Medical Center for Adults and Hyogo Cancer Center from January 1971 to December 1990 are presented. Two patients were stage 0, one stage I, three stage II and nine stage III. Nine patients received electron irradiation with or without interstitial irradiation and intracavitary vaginal irradiation. Five patients received megavoltage X-ray irradiation using AP/PA parallel opposed fields including the pelvic nodes and perineum followed by boost irradiation of electrons, interstitial irradiation and intracavitary vaginal irradiation. The total dose delivered to the primary tumor ranged from 50 to 100 Gy (73 Gy on average). The actuarial 5-year survival rate of the patients was 43.6%. Complete regression (CR) was achieved in 60% of the patients. However, CR was not achieved in any of five patients with palpable inguinal nodes. In contrast, all the patients who had tumors of less than 2 cm in diameter achieved CR. Five of nine CR cases relapsed. First sites of failure were vagina, groin and vulvar region. Recurrence occurred more than four years after treatment in three cases. Necrosis occurred in five of nine CR cases.
Hirota
S
S
Department of Radiology, Hyogo Medical Center for Adults.
Soejima
T
T
Motohara
T
T
Mieda
C
C
Suematsu
T
T
Obayashi
K
K
Takada
Y
Y
Yoshida
S
S
Hasegawa
K
K
Takeuchi
K
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D011882:Radiotherapy, High-Energy; D012189:Retrospective Studies; D015996:Survival Rate; D014846:Vulvar Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000532:radiotherapy*